y to provide fast access to patient results.
Instruments range from larger analyzers that process a high number of
patient samples to smaller instruments designed for medium and small-volume
facilities. Besides supplying standard CBC results, some instruments have
additional features to aid in the evaluation of more complex disease states
or infections including cancer, HIV and a variety of anemias.
About Abbott's Diagnostics Businesses
Abbott is a global leader in in vitro diagnostics and offers a broad
range of innovative instrument systems and tests for hospitals, reference
labs, molecular labs, blood banks, physician offices and clinics. With more
than 65,000 customers in more than 100 countries, Abbott's diagnostic
products offer customers automation, convenience, bedside testing, cost
effectiveness and flexibility. Abbott has helped transform the practice of
medical diagnosis from an art to a science through the company's commitment
to improving patient care and lowering costs. Abbott's history is filled
with examples of first-of-a-kind diagnostic products and significant
technological and research advancements.
About Abbott
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs more than 68,000 people and markets its products in more
than 130 countries.
Abbott's news releases and other information are available on the
company's Web site at http://www.abbott.com.
'/>"/>Page: 1 2 Related medicine news :1.
Abbott to Present at Bear Stearns Healthcare Conference2.
The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events3.
Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance4.
Abbott Declares 335th Consecutive Quarterly Dividend5.
Abbott Again Honored as Top Company for Working Moms6.
Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care7.
Abbott Hosts Conference Call for Third-Quarter Earnings8.
Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge9.
Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine10.
Abbott Again Honored as a Leader in Diversity11.
Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition